Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 1697

1.

Birth outcomes for Australian mother-infant pairs who received an influenza vaccine during pregnancy, 2012-2014: The FluMum study.

McHugh L, Andrews RM, Lambert SB, Viney KA, Wood N, Perrett KP, Marshall HS, Richmond P, O'Grady KF.

Vaccine. 2017 Feb 9. pii: S0264-410X(17)30155-X. doi: 10.1016/j.vaccine.2017.01.075. [Epub ahead of print]

PMID:
28190746
2.

Efficacy and Safety of Vaccination in Pediatric Patients with Systemic Inflammatory Rheumatic Diseases: a systematic review of the literature.

Sousa S, Duarte AC, Cordeiro I, Ferreira J, Gonçalves MJ, Meirinhos T, Rocha TM, Romão VC, Santos MJ.

Acta Reumatol Port. 2016 Nov 9. [Epub ahead of print]

PMID:
28133957
3.

Educating parents about the vaccination status of their children: A user-centered mobile application.

Seeber L, Conrad T, Hoppe C, Obermeier P, Chen X, Karsch K, Muehlhans S, Tief F, Boettcher S, Diedrich S, Schweiger B, Rath B.

Prev Med Rep. 2017 Jan 14;5:241-250. doi: 10.1016/j.pmedr.2017.01.002.

4.

The impact of a vaccine scare on parental views, trust and information needs: a qualitative study in Sydney, Australia.

King C, Leask J.

BMC Public Health. 2017 Jan 23;17(1):106. doi: 10.1186/s12889-017-4032-2.

5.

The effect of gamma-irradiation conditions on the immunogenicity of whole-inactivated Influenza A virus vaccine.

David SC, Lau J, Singleton EV, Babb R, Davies J, Hirst TR, McColl SR, Paton JC, Alsharifi M.

Vaccine. 2017 Feb 15;35(7):1071-1079. doi: 10.1016/j.vaccine.2016.12.044.

PMID:
28109709
6.

Cell-Based Systems Biology Analysis of Human AS03-Adjuvanted H5N1 Avian Influenza Vaccine Responses: A Phase I Randomized Controlled Trial.

Howard LM, Hoek KL, Goll JB, Samir P, Galassie A, Allos TM, Niu X, Gordy LE, Creech CB, Prasad N, Jensen TL, Hill H, Levy SE, Joyce S, Link AJ, Edwards KM.

PLoS One. 2017 Jan 18;12(1):e0167488. doi: 10.1371/journal.pone.0167488.

7.

Influenza in the Asia-Pacific region: Findings and recommendations from the Global Influenza Initiative.

Cowling BJ, Caini S, Chotpitayasunondh T, Djauzi S, Gatchalian SR, Huang QS, Koul PA, Lee PI, Muttalif AR, Plotkin S; Global Influenza Initiative..

Vaccine. 2017 Feb 7;35(6):856-864. doi: 10.1016/j.vaccine.2016.12.064. Review.

PMID:
28081970
8.

A New RNA-Based Adjuvant Enhances Virus-Specific Vaccine Responses by Locally Triggering TLR- and RLH-Dependent Effects.

Ziegler A, Soldner C, Lienenklaus S, Spanier J, Trittel S, Riese P, Kramps T, Weiss S, Heidenreich R, Jasny E, Guzmán CA, Kallen KJ, Fotin-Mleczek M, Kalinke U.

J Immunol. 2017 Feb 15;198(4):1595-1605. doi: 10.4049/jimmunol.1601129.

PMID:
28077601
9.

Despite awareness of recommendations, why do health care workers not immunize pregnant women?

Gesser-Edelsburg A, Shir-Raz Y, Hayek S, Aassaraf S, Lowenstein L.

Am J Infect Control. 2017 Jan 4. pii: S0196-6553(16)31088-4. doi: 10.1016/j.ajic.2016.11.025. [Epub ahead of print]

PMID:
28063725
10.

Time to Change Dosing of Inactivated Quadrivalent Influenza Vaccine in Young Children: Evidence From a Phase III, Randomized, Controlled Trial.

Jain VK, Domachowske JB, Wang L, Ofori-Anyinam O, Rodríguez-Weber MA, Leonardi ML, Klein NP, Schlichter G, Jeanfreau R, Haney BL, Chu L, Harris JS, Sarpong KO, Micucio AC, Soni J, Chandrasekaran V, Li P, Innis BL.

J Pediatric Infect Dis Soc. 2017 Jan 6. pii: piw068. doi: 10.1093/jpids/piw068. [Epub ahead of print]

PMID:
28062552
11.

Biodegradable nanoparticle delivery of inactivated swine influenza virus vaccine provides heterologous cell-mediated immune response in pigs.

Dhakal S, Hiremath J, Bondra K, Lakshmanappa YS, Shyu DL, Ouyang K, Kang KI, Binjawadagi B, Goodman J, Tabynov K, Krakowka S, Narasimhan B, Lee CW, Renukaradhya GJ.

J Control Release. 2017 Feb 10;247:194-205. doi: 10.1016/j.jconrel.2016.12.039.

PMID:
28057521
12.

Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development.

Volz A, Sutter G.

Adv Virus Res. 2017;97:187-243. doi: 10.1016/bs.aivir.2016.07.001. Review.

PMID:
28057259
13.

Generation of a genetically stable high-fidelity influenza vaccine strain.

Naito T, Mori K, Ushirogawa H, Takizawa N, Nobusawa E, Odagiri T, Tashiro M, Ohniwa RL, Nagata K, Saito M.

J Virol. 2017 Jan 4. pii: JVI.01073-16. doi: 10.1128/JVI.01073-16. [Epub ahead of print]

PMID:
28053101
14.

A Survey of Parental Perception and Pattern of Action in Response to Influenza-like Illness in Their Children: Including Healthcare Use and Vaccination in Korea.

Hwang JH, Lim CH, Kim DH, Eun BW, Jo DS, Song YH, Kim YK.

J Korean Med Sci. 2017 Feb;32(2):204-211. doi: 10.3346/jkms.2017.32.2.204.

15.

Improvement influenza HA2 DNA vaccine cellular and humoral immune responses with Mx bio adjuvant.

Soleimani S, Shahsavandi S, Maddadgar O.

Biologicals. 2016 Dec 24. pii: S1045-1056(16)30152-X. doi: 10.1016/j.biologicals.2016.11.004. [Epub ahead of print]

PMID:
28027847
16.

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).

Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, Carroll MW, Dean NE, Diatta I, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Gsell PS, Hossmann S, Watle SV, Kondé MK, Kéïta S, Kone S, Kuisma E, Levine MM, Mandal S, Mauget T, Norheim G, Riveros X, Soumah A, Trelle S, Vicari AS, Røttingen JA, Kieny MP.

Lancet. 2017 Feb 4;389(10068):505-518. doi: 10.1016/S0140-6736(16)32621-6.

17.

Randomized, double-blind, multi-center, phase III clinical trial to evaluate the immunogenicity and safety of MG1109 (egg-based pre-pandemic influenza A/H5N1 vaccine) in healthy adults.

Song JY, Choi MJ, Noh JY, Choi WS, Cheong HJ, Wie SH, Lee JS, Woo GJ, Lee SH, Kim WJ.

Hum Vaccin Immunother. 2016 Dec 20:0. [Epub ahead of print]

PMID:
27996363
18.

Surveillance of Adverse Events After Seasonal Influenza Vaccination in Pregnant Women and Their Infants in the Vaccine Adverse Event Reporting System, July 2010-May 2016.

Moro P, Baumblatt J, Lewis P, Cragan J, Tepper N, Cano M.

Drug Saf. 2017 Feb;40(2):145-152. doi: 10.1007/s40264-016-0482-1.

PMID:
27988883
19.

History and evolution of influenza control through vaccination: from the first monovalent vaccine to universal vaccines.

Barberis I, Myles P, Ault SK, Bragazzi NL, Martini M.

J Prev Med Hyg. 2016 Sep;57(3):E115-E120. Review.

20.

Attitudes and Beliefs of Pregnant Women and New Mothers Regarding Influenza Vaccination in British Columbia.

Bettinger JA, Greyson D, Money D.

J Obstet Gynaecol Can. 2016 Nov;38(11):1045-1052. doi: 10.1016/j.jogc.2016.08.004.

Items per page

Supplemental Content

Loading ...
Support Center